Maternal oral administration of osteocalcin protects offspring from metabolic impairment in adulthood

Tomoyo Kawakubo-Yasukochi, Akihiko Kondo, Akiko Mizokami, Yoshikazu Hayashi, Sakura Chishaki, Seiji Nakamura, Hiroshi Takeuchi, Masato Hirata

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective Maternal diet during pregnancy has been found to influence the health of offspring. However, strategies for modulation of maternal energy metabolism without an adverse effect on the fetus have remained limited. It was recently shown that oral administration of uncarboxylated osteocalcin (GluOC) improves metabolic status in adult female mice. Whether maternal GluOC administration during gestation might improve the metabolic status of offspring was investigated. Methods Female C57BL/6 mice were fed a normal diet (ND) or high-fat, high-sucrose diet (HFS) and were given saline or GluOC by oral administration during pregnancy. The resulting offspring were in turn assigned to ND- or HFS-fed groups immediately after weaning, and their body weight, glucose metabolism, serum lipid parameters, and level of adipose tissue inflammation were subsequently assessed. Results Maternal HFS feeding during gestation had adverse effects on glucose and lipid parameters, body weight, and adipose tissue inflammation in female offspring fed the same diet, and these effects were attenuated by maternal oral GluOC administration. Conclusions Maternal oral administration of GluOC protects HFS-fed female offspring from metabolic disorders induced by maternal obesity.

Original languageEnglish
Pages (from-to)895-907
Number of pages13
JournalObesity
Volume24
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Osteocalcin
Oral Administration
Mothers
Diet
Pregnancy
Adipose Tissue
Body Weight
Inflammation
Glucose
High Fat Diet
Weaning
Inbred C57BL Mouse
Lipid Metabolism
Energy Metabolism
Sucrose
Fetus
Obesity
Lipids
Health
Serum

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics

Cite this

Maternal oral administration of osteocalcin protects offspring from metabolic impairment in adulthood. / Kawakubo-Yasukochi, Tomoyo; Kondo, Akihiko; Mizokami, Akiko; Hayashi, Yoshikazu; Chishaki, Sakura; Nakamura, Seiji; Takeuchi, Hiroshi; Hirata, Masato.

In: Obesity, Vol. 24, No. 4, 01.04.2016, p. 895-907.

Research output: Contribution to journalArticle

Kawakubo-Yasukochi, T, Kondo, A, Mizokami, A, Hayashi, Y, Chishaki, S, Nakamura, S, Takeuchi, H & Hirata, M 2016, 'Maternal oral administration of osteocalcin protects offspring from metabolic impairment in adulthood', Obesity, vol. 24, no. 4, pp. 895-907. https://doi.org/10.1002/oby.21447
Kawakubo-Yasukochi, Tomoyo ; Kondo, Akihiko ; Mizokami, Akiko ; Hayashi, Yoshikazu ; Chishaki, Sakura ; Nakamura, Seiji ; Takeuchi, Hiroshi ; Hirata, Masato. / Maternal oral administration of osteocalcin protects offspring from metabolic impairment in adulthood. In: Obesity. 2016 ; Vol. 24, No. 4. pp. 895-907.
@article{7cf01e52f7124c75adbd6b812a10087f,
title = "Maternal oral administration of osteocalcin protects offspring from metabolic impairment in adulthood",
abstract = "Objective Maternal diet during pregnancy has been found to influence the health of offspring. However, strategies for modulation of maternal energy metabolism without an adverse effect on the fetus have remained limited. It was recently shown that oral administration of uncarboxylated osteocalcin (GluOC) improves metabolic status in adult female mice. Whether maternal GluOC administration during gestation might improve the metabolic status of offspring was investigated. Methods Female C57BL/6 mice were fed a normal diet (ND) or high-fat, high-sucrose diet (HFS) and were given saline or GluOC by oral administration during pregnancy. The resulting offspring were in turn assigned to ND- or HFS-fed groups immediately after weaning, and their body weight, glucose metabolism, serum lipid parameters, and level of adipose tissue inflammation were subsequently assessed. Results Maternal HFS feeding during gestation had adverse effects on glucose and lipid parameters, body weight, and adipose tissue inflammation in female offspring fed the same diet, and these effects were attenuated by maternal oral GluOC administration. Conclusions Maternal oral administration of GluOC protects HFS-fed female offspring from metabolic disorders induced by maternal obesity.",
author = "Tomoyo Kawakubo-Yasukochi and Akihiko Kondo and Akiko Mizokami and Yoshikazu Hayashi and Sakura Chishaki and Seiji Nakamura and Hiroshi Takeuchi and Masato Hirata",
year = "2016",
month = "4",
day = "1",
doi = "10.1002/oby.21447",
language = "English",
volume = "24",
pages = "895--907",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Maternal oral administration of osteocalcin protects offspring from metabolic impairment in adulthood

AU - Kawakubo-Yasukochi, Tomoyo

AU - Kondo, Akihiko

AU - Mizokami, Akiko

AU - Hayashi, Yoshikazu

AU - Chishaki, Sakura

AU - Nakamura, Seiji

AU - Takeuchi, Hiroshi

AU - Hirata, Masato

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Objective Maternal diet during pregnancy has been found to influence the health of offspring. However, strategies for modulation of maternal energy metabolism without an adverse effect on the fetus have remained limited. It was recently shown that oral administration of uncarboxylated osteocalcin (GluOC) improves metabolic status in adult female mice. Whether maternal GluOC administration during gestation might improve the metabolic status of offspring was investigated. Methods Female C57BL/6 mice were fed a normal diet (ND) or high-fat, high-sucrose diet (HFS) and were given saline or GluOC by oral administration during pregnancy. The resulting offspring were in turn assigned to ND- or HFS-fed groups immediately after weaning, and their body weight, glucose metabolism, serum lipid parameters, and level of adipose tissue inflammation were subsequently assessed. Results Maternal HFS feeding during gestation had adverse effects on glucose and lipid parameters, body weight, and adipose tissue inflammation in female offspring fed the same diet, and these effects were attenuated by maternal oral GluOC administration. Conclusions Maternal oral administration of GluOC protects HFS-fed female offspring from metabolic disorders induced by maternal obesity.

AB - Objective Maternal diet during pregnancy has been found to influence the health of offspring. However, strategies for modulation of maternal energy metabolism without an adverse effect on the fetus have remained limited. It was recently shown that oral administration of uncarboxylated osteocalcin (GluOC) improves metabolic status in adult female mice. Whether maternal GluOC administration during gestation might improve the metabolic status of offspring was investigated. Methods Female C57BL/6 mice were fed a normal diet (ND) or high-fat, high-sucrose diet (HFS) and were given saline or GluOC by oral administration during pregnancy. The resulting offspring were in turn assigned to ND- or HFS-fed groups immediately after weaning, and their body weight, glucose metabolism, serum lipid parameters, and level of adipose tissue inflammation were subsequently assessed. Results Maternal HFS feeding during gestation had adverse effects on glucose and lipid parameters, body weight, and adipose tissue inflammation in female offspring fed the same diet, and these effects were attenuated by maternal oral GluOC administration. Conclusions Maternal oral administration of GluOC protects HFS-fed female offspring from metabolic disorders induced by maternal obesity.

UR - http://www.scopus.com/inward/record.url?scp=84959544137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959544137&partnerID=8YFLogxK

U2 - 10.1002/oby.21447

DO - 10.1002/oby.21447

M3 - Article

C2 - 26945538

AN - SCOPUS:84959544137

VL - 24

SP - 895

EP - 907

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 4

ER -